This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Musser, J. M. Articles by Rudgers, G. W. Search for Related Content PubMed PubMed Citation Articles by Musser, J. M. Articles by Rudgers, G. W.

 Previous Article  |  Next Article 

Infect. Immun., 06 1996, 1913-1917, Vol 64, No. 6
Copyright © 1996, American Society for Microbiology

Substitution of cysteine 192 in a highly conserved Streptococcus pyogenes extracellular cysteine protease (interleukin 1beta convertase) alters proteolytic activity and ablates zymogen processing

JM Musser, K Stockbauer, V Kapur and GW Rudgers
Department of Pathology, Baylor College of Medicine, Houston, Texas 77030, USA.

Virtually all strains of the human pathogenic bacterium Streptococcus pyogenes express a highly conserved extracellular cysteine protease. The protein is made as an inactive zymogen of 40,000 Da and undergoes autocatalytic truncation to result in a 28,000-Da active protease. Numerous independent lines of investigation suggest that this enzyme participates in one or more phases of host-parasite interaction, such as inflammation and soft tissue invasion. Replacement of the single cysteine residue (C-192) with serine (C192S mutation) resulted in loss of detectable proteolytic activity against bovine casein, human fibronectin, and the low-molecular-weight synthetic substrate 7-amino-4- trifluoromethyl coumarin. The C192S mutant molecule does not undergo autocatalytic processing of zymogen to mature form. Taken together, these data support the hypothesis that C-192 participates in active- site formation and enzyme catalysis.

This article has been cited by other articles:

• Cole, J. N., McArthur, J. D., McKay, F. C., Sanderson-Smith, M. L., Cork, A. J., Ranson, M., Rohde, M., Itzek, A., Sun, H., Ginsburg, D., Kotb, M., Nizet, V., Chhatwal, G. S., Walker, M. J. (2006). Trigger for group A streptococcal M1T1 invasive disease. FASEB J. 20: 1745-1747 [Abstract] [Full Text]  
• Nyberg, P., Rasmussen, M., Bjorck, L. (2004). {alpha}2-Macroglobulin-Proteinase Complexes Protect Streptococcus pyogenes from Killing by the Antimicrobial Peptide LL-37. J. Biol. Chem. 279: 52820-52823 [Abstract] [Full Text]  
• Tamura, F., Nakagawa, R., Akuta, T., Okamoto, S., Hamada, S., Maeda, H., Kawabata, S., Akaike, T. (2004). Proapoptotic Effect of Proteolytic Activation of Matrix Metalloproteinases by Streptococcus pyogenes Thiol Proteinase (Streptococcus Pyrogenic Exotoxin B). Infect. Immun. 72: 4836-4847 [Abstract] [Full Text]  
• Banks, D. J., Lei, B., Musser, J. M. (2003). Prophage Induction and Expression of Prophage-Encoded Virulence Factors in Group A Streptococcus Serotype M3 Strain MGAS315. Infect. Immun. 71: 7079-7086 [Abstract] [Full Text]  
• Chen, C.-Y., Luo, S.-C., Kuo, C.-F., Lin, Y.-S., Wu, J.-J., Lin, M. T., Liu, C.-C., Jeng, W.-Y., Chuang, W.-J. (2003). Maturation Processing and Characterization of Streptopain. J. Biol. Chem. 278: 17336-17343 [Abstract] [Full Text]  
• Massimi, I., Park, E., Rice, K., Muller-Esterl, W., Sauder, D., McGavin, M. J. (2002). Identification of a Novel Maturation Mechanism and Restricted Substrate Specificity for the SspB Cysteine Protease of Staphylococcus aureus. J. Biol. Chem. 277: 41770-41777 [Abstract] [Full Text]  
• Watanabe, Y., Todome, Y., Ohkuni, H., Sakurada, S., Ishikawa, T., Yutsudo, T., Fischetti, V. A., Zabriskie, J. B. (2002). Cysteine Protease Activity and Histamine Release from the Human Mast Cell Line HMC-1 Stimulated by Recombinant Streptococcal Pyrogenic Exotoxin B/Streptococcal Cysteine Protease. Infect. Immun. 70: 3944-3947 [Abstract] [Full Text]  
• Lei, B., Mackie, S., Lukomski, S., Musser, J. M. (2000). Identification and Immunogenicity of Group A Streptococcus Culture Supernatant Proteins. Infect. Immun. 68: 6807-6818 [Abstract] [Full Text]  
• Cunningham, M. W. (2000). Pathogenesis of Group A Streptococcal Infections. Clin. Microbiol. Rev. 13: 470-511 [Abstract] [Full Text]  
• Gubba, S., Cipriano, V., Musser, J. M. (2000). Replacement of Histidine 340 with Alanine Inactivates the Group A Streptococcus Extracellular Cysteine Protease Virulence Factor. Infect. Immun. 68: 3716-3719 [Abstract] [Full Text]  
• Matsuka, Y. V., Pillai, S., Gubba, S., Musser, J. M., Olmsted, S. B. (1999). Fibrinogen Cleavage by the Streptococcus pyogenes Extracellular Cysteine Protease and Generation of Antibodies That Inhibit Enzyme Proteolytic Activity. Infect. Immun. 67: 4326-4333 [Abstract] [Full Text]  
• Federle, M. J., McIver, K. S., Scott, J. R. (1999). A Response Regulator That Represses Transcription of Several Virulence Operons in the Group A Streptococcus. J. Bacteriol. 181: 3649-3657 [Abstract] [Full Text]  
• Stockbauer, K. E., Magoun, L., Liu, M., Burns, E. H. Jr., Gubba, S., Renish, S., Pan, X., Bodary, S. C., Baker, E., Coburn, J., Leong, J. M., Musser, J. M. (1999). A natural variant of the cysteine protease virulence factor of group A Streptococcus with an arginine-glycine-aspartic acid (RGD) motif preferentially binds human integrins alpha vbeta 3 and alpha IIbbeta 3. Proc. Natl. Acad. Sci. USA 96: 242-247 [Abstract] [Full Text]  
• Gubba, S., Low, D. E., Musser, J. M. (1998). Expression and Characterization of Group A Streptococcus Extracellular Cysteine Protease Recombinant Mutant Proteins and Documentation of Seroconversion during Human Invasive Disease Episodes. Infect. Immun. 66: 765-770 [Abstract] [Full Text]  
• Kagawa, T. F., Cooney, J. C., Baker, H. M., McSweeney, S., Liu, M., Gubba, S., Musser, J. M., Baker, E. N. (2000). From the Cover: Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: An integrin-binding cysteine protease. Proc. Natl. Acad. Sci. USA 97: 2235-2240 [Abstract] [Full Text]